Cervical Cancer More Prevalent Than Expected

Published Online: Tuesday, June 17, 2014
Follow Pharmacy_Times:
According to the results of recent study, cervical cancer rates in the United States may be much higher than previously thought, especially among older women.

The risk of invasive cervical cancer is thought to decline in women older than 65 years, and routine screening for the disease is only recommended up until this age. Previous estimates of cervical cancer prevalence, however, do not account for women who have had hysterectomies. The study, published online on May 12, 2014, in Cancer, recalculated rates of cervical cancer, adjusting for hysterectomy rates from the Behavioral Risk Factor Surveillance System.

When women with hysterectomies were excluded, the overall prevalence of cervical cancer was 18.6 cases per 100,000 women, while previous studies estimated prevalence to be approximately 12 per 100,000. The result also indicated that cervical cancer rates continued to rise among women after 35 to 39 years of age, although at a slower rate than for those aged 20 to 34 years. In the current study, cervical cancer incidence was highest among women aged 65 to 69 years, with a rate of 27.4 cases per 100,000, while previous estimates indicated that prevalence was highest among women aged 40 to 44 years, with a rate of 15.6 cases per 100,000.

Related Articles
Celgene today announced that the FDA has granted an expanded use approval for its multiple myeloma drug, lenalidomide (Revlimid).
Although testosterone is often considered to be a catalyst of prostate cancer, a recent study suggests that the hormone may be able to subdue advanced prostate cancer and break down resistance to testosterone-blocking drugs used to treat the disease.
A vaccine therapy that stimulates the body’s own immune defenses is safe to give to prostate cancer patients early in the disease’s progression, a recent study found.
Researchers have developed a personalized genetic test that can accurately predict the risk for recurrence in prostate cancer patients.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$